Delivering Solid Form Solutions with Decades of Expertise – Your Partner for Solid State and Preclinical Formulation Services.
CONTACT
- info@solitekpharma.com
- [+34] 614 65 22 57
- Parc Científic de Barcelona, Carrer de Baldiri Reixac, 10-12 (08028)
Comprehensive characterization of stable and metastable forms, hydrates, and solvates to ensure optimal performance.
Micro-screening protocols designed to maximize the use of valuable API grams during Discovery and Early Development work.
Cutting-edge instrumentation and techniques deliver precise, reliable characterization of every solid form.
More than 40 years dedicated to solid-state science, its development, and optimization.
Unexpected polymorphic changes during development or scale-up that stall your regulatory filing.
API degradation or changes in dissolution rate caused by a poorly understood solid-state form.
Filing on an incomplete or incorrect characterization creates a weak patent that fails to protect what you're actually manufacturing.
Incomplete solid state characterization at lab scale leads to unpredictable behavior at plant scale, causing downtime and serious quality failures.
Advancing to complex formulation systems without fully understanding the API's actual interaction with excipients results in loss of bioavailability and failed stability testing.
We solve unexpected differences in dissolution or hygroscopicity between seemingly identical batches by identifying the root solid-state cause.
High-precision structural characterization using state-of-the-art analytical techniques (XRD, DSC, TGA, DVS).
We assess solid-state behavior under thermal stress, humidity, and mechanical stress (grinding) to define optimal storage and process conditions.
Posted on Google
Neil SimTrustindex verifies that the original source of the review is Google.
At HFR, we have collaborated with Solitek across numerous projects for a number of years. Across all projects that we have collaborated on, I have felt that Solitek really work to fully understand the project from the outset. Victor, Steve and all of the team provide expert knowledge across the solid state landscape and combine a methodical approach with scientific rigour. Their communication and reporting is thorough and clearly presented, providing further value when working on more challenging and complex landscapes.Posted on Google
Anthony DebonoTrustindex verifies that the original source of the review is Google.
I have collaborated directly with Solitek on a number of projects. I highly recommend the team. They combine deep technical expertise and experimental know-how, with an efficient and collaborative customer service. Thanks to their decades of experience in the field they are able to give solid advice on development approaches and are proactive and transparent during project execution.Posted on Google
Josep CastellsTrustindex verifies that the original source of the review is Google.
La experiencia con Solitek durante el desarrollo de una molécula activa farmacéuticamente fue muy positiva por su gran profesionalidad y la capacidad de superar los retoques técnicos.Posted on Google
Adria Espinas TorresTrustindex verifies that the original source of the review is Google.
Great experience working with Solitek from Farmhispania Group on solid-state projects. We collaborated in the development of robust and scalable API crystallization processes and solid form selection and characterization, and they always bring clear, practical solutions. Working with Steve, Víctor, and the rest of the team has been very smooth, with close and easy communication throughout. They are agile, adapt well to project needs, and are strongly results-oriented. Strongly recommended!Posted on Google
DavidTrustindex verifies that the original source of the review is Google.
AKL Therapeutics had approached Solitek regarding an unusual and difficult issue associated with a liquid eutectic formulation. Solitek devised a clear and systematic plan of investigations to solve the outstanding problems and were well equipped to conduct the necessary specialist studies in this area. The staff have very good practical knowledge and experience in the area of pharmaceutical formulation development. The investigations Solitek conducted proved to be fully enlightening as to and understanding of key issues involved in the development of a suitable formulation for the concerned molecules. The standard of reporting was excellent with regular scheduled updates that were well communicated by the Solitek team. We would certainly recommend Solitek as a competent and capable partner in the area of pharmaceutical formulation development. John McCrerie for AKL TherapeuticsPosted on Google
Ernesto Durán LópezTrustindex verifies that the original source of the review is Google.
Over the past few years, we have carried out several collaborations with Solitek to address different aspects related to the solid‑state development of pharmaceutical active ingredients. These projects have included salt‑screening studies to modulate API solubility, the exploration of new polymorphic forms and co‑crystals to help overcome IP barriers, and the optimization of process parameters to enhance the robustness of crystallizations at industrial scale. Throughout all these collaborations, the Solitek team has consistently demonstrated strong technical expertise, provided high‑value scientific input, met every agreed timeline, and delivered reports of outstanding quality. Without a doubt, having them by our side when complex challenges arise makes a real difference.Posted on Google
DBS ChenTrustindex verifies that the original source of the review is Google.
With over 20 yrs of outsourcing experience, I have to say Solitek is efficient, comprehensive, and budget-friendly. Their expertise gives me peace of mind when they handle my projects.Posted on Google
Marta MonjoTrustindex verifies that the original source of the review is Google.
Solitek nos ha ayudado muchísimo en la optimización y el escalado de nuestro proceso. Han demostrado un gran conocimiento técnico y una excelente capacidad para encontrar soluciones prácticas a los retos que han ido surgiendo durante el proyecto. Los estudios de familiarización realizados posteriormente en planta kilo-lab fueron todo un éxito y nos aportaron información muy útil para seguir avanzando. Además, durante todo el proceso de industrialización han seguido brindándonos apoyo y asesoramiento ante cualquier consulta o necesidad que ha surgido, demostrando un gran compromiso con el éxito del proyecto. Ha sido un placer trabajar con un equipo tan profesional, cercano y comprometido. Muchas gracias!Posted on Google
I MaikelTrustindex verifies that the original source of the review is Google.
Nuestras colaboraciones con Solitek han sido muy satisfactorias. Su profundo conocimiento del estado sólido, y de los procesos de optimización y escalado han rendido procesos sólidos, fiables, bien documentados y fáciles de transferir. Un placer trabajar con ellos.Posted on Google
Jacques Alain BauerTrustindex verifies that the original source of the review is Google.
The experience with Solitek Pharma projects were perfect, with real-time communication, very flexible collaboration and excellent reporting.
Solitek Pharma was founded to reduce risk and prevent costly failures in small molecule drug development, drawing on over 50 years of accumulated experience in the pharmaceutical industry, including more than 40 years focused specifically on solid-state science.
Our expertise was built at internationally recognized pharmaceutical companies such as GSK, Johnson Matthey, and Almac, Spanish companies such as Esteve and Medichem, and specialized solid-state teams such as Pharmorphix and Enantia.
We have participated in more than 1,000 drug development programs, giving us the practical perspective needed to approach each project with a clear sense of what truly needs to be accomplished and decided at every stage.
Our current company, Solitek Pharma, was founded in 2021 and is based at the Barcelona Science Park (Parc Científic de Barcelona), a hub for operations and specialized talent in our sector.
We are an agile team of experts who work closely with our clients, integrating as an extension of their development teams. We focus on what’s needed here and now, helping projects advance with lower risk and greater value for future partners.
We analyze your existing API data, identify crystallization risks, and define key objectives (polymorph, PSD, purity, yield)
We execute the work plan at our facilities in the Barcelona Science Park, using advanced characterization and screening tools to reduce risk and optimize every phase of the process.
We deliver a detailed, actionable technical report, ready for use in regulatory audits or direct transfer to your CDMO.
Our microscale protocols are optimized to work with very small quantities (100 – 500 mg), making them ideal for early-stage phases where material is scarce and expensive.
Thoroughly characterizing a crystalline form’s thermodynamic properties and stability allows patent claims to be drafted with precision and defensibility — ensuring the patent accurately reflects and protects the actual form you’re manufacturing.
Yes. All of our studies are conducted under strict quality standards with full traceability, specifically designed to integrate seamlessly into the chemistry sections of your IND or IMPD filings.
Polymorph screening focuses on the systematic discovery and mapping of all possible crystalline forms (polymorphs, salts, hydrates, and solvates) that an API can adopt.
On the other hand, in-depth structural characterization, thoroughly analyzes the thermodynamic stability, phase behavior, and physicochemical properties of selected forms to confirm their viability for pharmaceutical development and regulatory submission.
Don’t let polymorphism risks or solid-state instability stall your patents or delay your regulatory filing.
Partner with Solitek’s advanced characterization experts to ensure maximum stability, safeguard your intellectual property, and confidently accelerate your path to clinical trials.
Delivering Solid Form Solutions with Decades of Expertise – Your Partner for Solid State and Preclinical Formulation Services.
Solid Technologies has participated in the ICEX-Next Export Initiation Program, and has had the support of ICEX, as well as the financing of European ERDF Funds, having contributed to the economic growth of this company, its region and Spain as a whole.